uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
24.93
-2.12 (-7.84%)
At close: May 18, 2026, 4:00 PM EDT
24.41
-0.52 (-2.09%)
Pre-market: May 19, 2026, 6:14 AM EDT
uniQure Revenue
uniQure had revenue of $3.56M in the quarter ending March 31, 2026, a decrease of -31.78%.
Revenue (ttm)
$18.09M
Revenue Growth
-10.44%
P/S Ratio
86.90
Revenue / Employee
$81,869
Employees
221
Market Cap
1.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 27.12M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 106.48M | -417.52M | -79.68% |
| Dec 31, 2021 | 524.00M | 486.49M | 1,296.82% |
| Dec 31, 2020 | 37.51M | 30.23M | 415.23% |
| Dec 31, 2019 | 7.28M | -4.00M | -35.48% |
| Dec 31, 2018 | 11.28M | -1.82M | -13.91% |
| Dec 31, 2017 | 13.11M | -11.99M | -47.78% |
| Dec 31, 2016 | 25.10M | 14.52M | 137.27% |
| Dec 31, 2015 | 10.58M | 4.44M | 72.25% |
| Dec 31, 2014 | 6.14M | 2.09M | 51.74% |
| Dec 31, 2013 | 4.05M | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | 68.42K | -174.98K | -71.89% |
| Dec 31, 2005 | 243.40K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ardelyx | 427.68M |
| Innoviva | 420.69M |
| Iovance Biotherapeutics | 285.61M |
| Nurix Therapeutics | 71.78M |
| Recursion Pharmaceuticals | 66.41M |
| Monte Rosa Therapeutics | 42.95M |
| Capricor Therapeutics | 11.13M |
| Taysha Gene Therapies | 7.47M |
QURE News
- 12 days ago - uniQure price target lowered to $50 from $70 at H.C. Wainwright - TheFly
- 13 days ago - uniQure price target raised to $28 from $14 at Stifel - TheFly
- 13 days ago - uniQure Earnings Call Transcript: Q1 2026 - Transcripts
- 13 days ago - uniQure Earnings release: Q1 2026 - Filings
- 13 days ago - uniQure Quarterly report: Q1 2026 - Filings
- 13 days ago - uniQure reports Q1 EPS (85c), consensus (75c) - TheFly
- 13 days ago - uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates - GlobeNewsWire
- 18 days ago - uniQure price target raised to $37 from $31 at Chardan - TheFly